SUMMARY OBJECTIVE: Bilharziosis is one of the most important helminthal infections in humans and is caused by blood flukes of the genus Schistosoma. Three different life stages of the parasite occur within the mammalian host: schistosomula located in the skin, pre-adults located in the lung and adult worms located in the portal venous system. Erythrocytes are a major source of nutrient supply for adults. However, sources of nutrition for the developing stages are still unclear. METHODS: To investigate whether schistosomula, pre-adults and adults of Schistosoma mansoni ingest human serum albumin (HSA) in vitro, these life stages were incubated with aminofluorescein-labelled human serum albumin (Afl-HSA) for 5 h. To test the uptake of albumin in vivo, the albumin conjugate was given intravenously to S. mansoni infected NMRI mice 24 h before harvesting the 3 life stages. RESULTS: In comparison to the control group schistosomula, pre-adults, and adults showed an accumulation of Afl-HSA within the oesophagus and intestinal caecum in vitro and in vivo. CONCLUSION: Our findings suggest that albumin seems to be a major source of energy supply for the early schistosomal life stages and an additive energy support for adult worms. Since albumin has been used successfully as a drug carrier for chemotherapeutic substances against malignant disorders, further studies will focus on albumin as a carrier for anthelminthics in a drug-targeting model.
SUMMARY OBJECTIVE: Bilharziosis is one of the most important helminthal infections in humans and is caused by blood flukes of the genus Schistosoma. Three different life stages of the parasite occur within the mammalian host: schistosomula located in the skin, pre-adults located in the lung and adult worms located in the portal venous system. Erythrocytes are a major source of nutrient supply for adults. However, sources of nutrition for the developing stages are still unclear. METHODS: To investigate whether schistosomula, pre-adults and adults of Schistosoma mansoni ingest human serum albumin (HSA) in vitro, these life stages were incubated with aminofluorescein-labelled human serum albumin (Afl-HSA) for 5 h. To test the uptake of albumin in vivo, the albumin conjugate was given intravenously to S. mansoni infected NMRI mice 24 h before harvesting the 3 life stages. RESULTS: In comparison to the control group schistosomula, pre-adults, and adults showed an accumulation of Afl-HSA within the oesophagus and intestinal caecum in vitro and in vivo. CONCLUSION: Our findings suggest that albumin seems to be a major source of energy supply for the early schistosomal life stages and an additive energy support for adult worms. Since albumin has been used successfully as a drug carrier for chemotherapeutic substances against malignant disorders, further studies will focus on albumin as a carrier for anthelminthics in a drug-targeting model.
Authors: Ariane S Blohm; Patrick Mäder; Thomas Quack; Zhigang Lu; Steffen Hahnel; Martin Schlitzer; Christoph G Grevelding Journal: Parasitol Res Date: 2016-05-26 Impact factor: 2.289
Authors: Jipeng Wang; Shuqi Wang; Xiufeng Liu; Bin Xu; Riyi Chai; Pan Zhou; Chuan Ju; Jun Sun; Paul J Brindley; Wei Hu Journal: PLoS One Date: 2015-05-15 Impact factor: 3.240
Authors: Vicente P Martins; Suellen B Morais; Carina S Pinheiro; Natan R G Assis; Barbara C P Figueiredo; Natasha D Ricci; Juliana Alves-Silva; Marcelo V Caliari; Sergio C Oliveira Journal: PLoS Negl Trop Dis Date: 2014-03-20
Authors: Svenja Beckmann; Thavy Long; Christina Scheld; Rudolf Geyer; Conor R Caffrey; Christoph G Grevelding Journal: Int J Parasitol Drugs Drug Resist Date: 2014-08-07 Impact factor: 4.077
Authors: Tobias Lindner; Jan Stenzel; Nicole Koslowski; Alexander Hohn; Änne Glass; Sarah M Schwarzenböck; Bernd J Krause; Brigitte Vollmar; Emil C Reisinger; Martina Sombetzki Journal: Sci Rep Date: 2020-10-15 Impact factor: 4.379
Authors: Ross A Paveley; Nuha R Mansour; Irene Hallyburton; Leo S Bleicher; Alex E Benn; Ivana Mikic; Alessandra Guidi; Ian H Gilbert; Andrew L Hopkins; Quentin D Bickle Journal: PLoS Negl Trop Dis Date: 2012-07-31
Authors: Suellen B Morais; Barbara C Figueiredo; Natan R G Assis; Jane Homan; Fábio S Mambelli; Rodrigo M Bicalho; Cláudia Souza; Vicente P Martins; Carina S Pinheiro; Sergio C Oliveira Journal: Front Immunol Date: 2018-07-30 Impact factor: 7.561